NEW YORK, NY -- (Marketwire) -- 08/07/08 -- CLX Medical, Inc. (OTCBB: CLXN) announced
today Positive Results of meetings at American Association for Clinical
Chemistry (AACC) Annual Meeting and Clinical Lab Expo.
CLX Medical, which is focused on the launch and distribution of unique
medical diagnostic testing products, reached an agreement with a major
European distributor to serve as the sole importer of CLX's subsidiary
products into the European market.
Information, opinions and analysis contained herein are based on sources
believed to be reliable, but no representation, expressed or implied, is
made as to its accuracy, completeness or correctness. The opinions
contained herein reflect our current judgment and are subject to change
without notice. We accept no liability for any losses arising from an
investor's reliance on or use of this report. This report is for
information purposes only, and is neither a solicitation to buy nor an
offer to sell securities. A Third Party has hired and paid IO News Wire
$2495.00 for the publication and circulation of this report. Certain
information included herein is forward-looking within the meaning of the
Private Securities Litigation Reform Act of 1995, including, but not
limited to, statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important risks and
uncertainties that could affect actual results and cause them to differ
materially from expectations expressed herein. We have no ownership of
equity, no representation do no trading of any kind and send No Faxes or
emails.